IQ-AI logo

IQAI - IQ-AI Share Price

4.9p -0.1  -2.0%

Last Trade - 06/12/19

Sector
Healthcare
Size
Micro Cap
Market Cap £6.85m
Enterprise Value £6.61m
Revenue £181k
Position in Universe 1593rd / 1840
Bullish
Bearish
Unlock IQAI Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

IQAI Revenue Unlock IQAI Revenue

Net Income

IQAI Net Income Unlock IQAI Revenue

Normalised EPS

IQAI Normalised EPS Unlock IQAI Revenue

PE Ratio Range

IQAI PE Ratio Range Unlock IQAI Revenue

Dividend Yield Range

IQAI Dividend Yield Range Unlock IQAI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
IQAI EPS Forecasts Unlock IQAI Revenue
Profile Summary

IQ-AI Limited, formerly Flying Brands Limited, is a Jersey-based medical services and software company. The Company provides health care technology solutions to the artificial intelligence (AI) medical imaging market. Through its subsidiary, StoneChecker Software Ltd, It offers medical imaging software for urolithiasis that analyses and presents stone metrics, including stone size, volume, density, skin to stone distance, and stone architecture through TexRAD analysis within the healthcare information technology (IT) systems. Through its subsidiary, Imaging Biometrics, LLC, It specializes in the design and manufacture of visualization tools, the application of machine learning and AI software solutions, and the development and clinical testing of imaging endpoints and biomarkers. Its portfolio consists of IB Neuro and IB Diffusion that are used in treatment of brain tumors, strokes and pathologies.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated November 5, 1965
Public Since March 15, 1996
No. of Shareholders: n/a
No. of Employees: 207
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange London Stock Exchange (Full)
Shares in Issue 139,830,982
Free Float (0.0%)
Eligible for
ISAs
SIPPs
IQAI Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for IQAI
Upcoming Events for IQAI
Similar to IQAI
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.